Modifications of the synaptosomal dopamine uptake and release by two systems generating free radicals: ascorbic acid/Fe2+ and L-arginine/NADPH.
Ramassamy
C
C
Unité de Neuropsychopharmacologie CNRS URA 1170, Faculté de Médecine & Pharmacie de Rouen, Saint-Etienne du Rouvray, France.
Girbe
F
F
Pincemail
J
J
Christen
Y
Y
Costentin
J
J
D000704:Analysis of Variance; D000818:Animals; D001120:Arginine / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D018491:Dopamine Agonists / Q000378:metabolism; D005609:Free Radicals / Q000378:metabolism / Q000494:pharmacology; D007501:Iron / Q000494:pharmacology*; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D051379:Mice; D009249:NADP / Q000494:pharmacology*; D010879:Piperazines / Q000378:metabolism; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism*; D014316:Tritium; D014810:Vitamin E / Q000378:metabolism
D018491:Dopamine Agonists; D005609:Free Radicals; D010879:Piperazines; D014316:Tritium; D014810:Vitamin E; D008315:Malondialdehyde; D009249:NADP; C039737:1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine; D001120:Arginine; D007501:Iron; D001205:Ascorbic Acid; D004298:Dopamine